Study uncovers epigenetic source of resistance to targeted therapy in EGFR-mutant lung cancer
by Dana-Farber Cancer InstituteCredit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.07.005When lung cancers driven by mutations in the EGFR gene become resistant to osimertinib or othe
Updated on: February 01,2024
Study uncovers epigenetic source of resistance to targeted therapy in EGFR-mutant lung cancer
by Dana-Farber Cancer InstituteCredit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.07.005When lung cancers driven by mutations in the EGFR gene become resistant to osimertinib or othe
Updated on:February 01,2024
